| ²é¿´: 1548 | »Ø¸´: 5 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
¶£ßË99ͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÔÙÆÕÀÖ£¨°ÂµªÆ½olanzapineƬ¼Á£©ÃÀ¹úÒ©µä±ê×¼¼°´¦·½×ÊÁÏ
|
||
Çó¸÷λ°ï棬ÀñÀ´¹«Ë¾µÄÉÌÆ·ÃûΪÔÙÆÕÀÖ£¨ZYPREXA £©µÄ£¨°ÂµªÆ½olanzapineƬ¼Á£© ÃÀ¹úÒ©µä±ê×¼¡£ÈôÓд¦·½×ÊÁϾ͸üºÃÁË¡£Ð»Ð»![]() |
» ²ÂÄãϲ»¶
ÇëÎÊÔõô²ÅÄÜÔÚÓÐôÈ»ù´æÔÚµÄÇé¿öÏ£¬Ö»¸ø·ÓôÇ»ùÉϼ׻ù
ÒѾÓÐ4È˻ظ´
²©µ¼ÍƼö
ÒѾÓÐ2È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ239È˻ظ´
ÄÄÀï×ö¸Ê°±ËáÊÜÌåÓëÅäÌå½áºÏÂʵÄÊÔÑé
ÒѾÓÐ0È˻ظ´
²Î±ÈÖÆ¼Á£¬×Ô¼º×öµÄPKÊý¾ÝÓëIF×ÊÁϱ¨µÀµÄÊý¾ÝÏà²îºÜ´ó
ÒѾÓÐ2È˻ظ´
ÆíÇóÖб¾×Ó
ÒѾÓÐ0È˻ظ´
¸÷λ´óÀУ¬H¿ÚÃæÉÏʲôʱºò»áÆÀ£¿£¿£¿
ÒѾÓÐ30È˻ظ´
¹ØÓÚSCIÔÓÖ¾·¢±í¹ÒÃû
ÒѾÓÐ32È˻ظ´
2026Äêɽ¶«´óѧº£ÑóѧԺÉúÎïÓëÒ½Ò©²©Ê¿ÕÐÉú-Àîϼ¿ÎÌâ×é
ÒѾÓÐ0È˻ظ´
²©Ê¿Ñо¿ÉúÕÐÉú
ÒѾÓÐ0È˻ظ´
Ò©Àíѧ¡¢ÁÙ´²Ò©Ñ§·½Ïò µ÷¼Á
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖú¿¨ÅàËû±õÃÀ¹úÒ©µä
ÒѾÓÐ8È˻ظ´
ÃÀ¹úÒ©µäÀïµÄMºÍN´ú±íʲôµ¥Î»
ÒѾÓÐ8È˻ظ´
Í¿²ãÊÔÑù²»Âú×ã²âÊÔ±ê×¼¹æ¶¨µÄÊÔÑù³ß´ç£¬Æä²âÊÔÖµ¿ÉÐŶȴ󲻴ó£¿
ÒѾÓÐ34È˻ظ´
°ÂÃÀÀßò³¦ÈܽºÄÒ ÃÀ¹úÒ©µä±ê×¼
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿ÃÀ¹úÒ©µäÖÐÒ»¶ÎÔÎĵķÒëÎÊÌâ
ÒѾÓÐ4È˻ظ´
¡¾ÇóÖú¡¿ÃÀ¹úÒ©µä33°æ
ÒѾÓÐ5È˻ظ´
¡¾ÇóÖú¡¿ÔõôÔÚÃÀ¹úÒ©µä²éÖÐÒ©±ê×¼£¿
ÒѾÓÐ7È˻ظ´
¹ØÓÚÃÀ¹úÒ©µäµÄÒÉÎÊ
ÒѾÓÐ4È˻ظ´
XiaOliAngeR
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 45 (СѧÉú)
- ½ð±Ò: 2785.8
- ºì»¨: 2
- Ìû×Ó: 211
- ÔÚÏß: 148.9Сʱ
- ³æºÅ: 1943725
- ×¢²á: 2012-08-17
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¶£ßË99: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-08-20 16:09:50
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¶£ßË99: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-08-20 16:09:50
|
ÕâÊÇÁùÆßÔÂ×îеÄÐÞ¶©°æ olanzapine-m58486.pdf µÈ2¸öÎļþ http://kuai.xunlei.com/d/GFTESOWZANVM?p=130497 |
4Â¥2012-08-19 12:56:01
hardee
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
´Ë²ÝÓÐÖ÷~
- DRDEPI: 12
- Ó¦Öú: 152 (¸ßÖÐÉú)
- ¹ó±ö: 0.03
- ½ð±Ò: 10929.3
- É¢½ð: 5544
- ºì»¨: 49
- ɳ·¢: 40
- Ìû×Ó: 6865
- ÔÚÏß: 2905.6Сʱ
- ³æºÅ: 891544
- ×¢²á: 2009-11-02
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhychen2008: ½ð±Ò+1, Ó¦ÖúÖ¸Êý+1, ¸Ðл»ØÌû½»Á÷ 2012-08-18 23:22:00
zhychen2008: ½ð±Ò+1, Ó¦ÖúÖ¸Êý-1, ÒѾÓÐÒ»¸öÓ¦ÖúÖ¸Êý 2012-08-18 23:22:49
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zhychen2008: ½ð±Ò+1, Ó¦ÖúÖ¸Êý+1, ¸Ðл»ØÌû½»Á÷ 2012-08-18 23:22:00
zhychen2008: ½ð±Ò+1, Ó¦ÖúÖ¸Êý-1, ÒѾÓÐÒ»¸öÓ¦ÖúÖ¸Êý 2012-08-18 23:22:49
|
http://d.dxy.cn/preview/4282022 http://d.dxy.cn/preview/4282023 Ö»ÄÜ¿´£¬Èç¹ûÏµĻ°£¬ÐèÒª¶£µ± |

2Â¥2012-08-18 22:23:18
¶£ßË99
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 484.2
- É¢½ð: 30
- Ìû×Ó: 253
- ÔÚÏß: 123.8Сʱ
- ³æºÅ: 933459
- ×¢²á: 2009-12-26
- ÐÔ±ð: MM
- רҵ: Ò©¼Áѧ
3Â¥2012-08-19 09:31:10
hardee
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
´Ë²ÝÓÐÖ÷~
- DRDEPI: 12
- Ó¦Öú: 152 (¸ßÖÐÉú)
- ¹ó±ö: 0.03
- ½ð±Ò: 10929.3
- É¢½ð: 5544
- ºì»¨: 49
- ɳ·¢: 40
- Ìû×Ó: 6865
- ÔÚÏß: 2905.6Сʱ
- ³æºÅ: 891544
- ×¢²á: 2009-11-02
- ÐÔ±ð: GG
- רҵ: Ò©Îﻯѧ
¡ï ¡ï
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó³£À´Å¶ 2012-08-20 16:21:50
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, лл½»Á÷£¬»¶Ó³£À´Å¶ 2012-08-20 16:21:50
|
¹ØÓÚÈܳö·½ÃæµÄÐÅÏ¢£¬USP±ê×¼Àï²»ÊÇÓÐÈܳöÕâÒ»Ïî±ê×¼Â𣿠ÖÁÓÚ´¦·½·½ÃæµÄÐÅÏ¢£¬Ö»ÄܸøÄã³É·Ö£¬µ«¾ßÌ庬Á¿£¬ÐèÒªÄã×Ô¼ºÈ¥²éѯÏà¹ØµÄÖÆ¼ÁרÀûÁË¡£ ZYPREXA tablets are intended for oral administration only. Each tablet contains olanzapine equivalent to 2.5 mg (8 µmol), 5 mg (16 µmol), 7.5 mg (24 µmol), 10 mg (32 µmol), 15 mg (48 µmol), or 20 mg (64 µmol). Inactive ingredients are carnauba wax, crospovidone, hydroxypropyl cellulose, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, and other inactive ingredients. The color coating contains Titanium Dioxide (all strengths), FD&C Blue No. 2 Aluminum Lake (15 mg), or Synthetic Red Iron Oxide (20 mg). The 2.5, 5, 7.5, and 10 mg tablets are imprinted with edible ink which contains FD&C Blue No. 2 Aluminum Lake. ZYPREXA ZYDIS (olanzapine orally disintegrating tablets) is intended for oral administration only. Each orally disintegrating tablet contains olanzapine equivalent to 5 mg (16 µmol), 10 mg (32 µmol), 15 mg (48 µmol) or 20 mg (64 µmol). It begins disintegrating in the mouth within seconds, allowing its contents to be subsequently swallowed with or without liquid. ZYPREXA ZYDIS (olanzapine orally disintegrating tablets) also contains the following inactive ingredients: gelatin, mannitol, aspartame, sodium methyl paraben, and sodium propyl paraben. ZYPREXA IntraMuscular (olanzapine for injection) is intended for intramuscular use only. Each vial provides for the administration of 10 mg (32 µmol) olanzapine with inactive ingredients 50 mg lactose monohydrate and 3.5 mg tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been added during manufacturing to adjust pH. |

5Â¥2012-08-20 12:23:42














»Ø¸´´ËÂ¥
